PBLA News and Press, Panbela Therapeutics Inc Com From 02/15/24

2024-02-15 09:22:43 ET More on Panbela Therapeutics Panbela Therapeutics closes ~$9M public offering of shares Panbela Therapeutics drops on $9M public offering Seeking Alpha’s Quant Rating on Panbela Therapeutics Read the full article on Seeking Alp...

MINNEAPOLIS, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that, has regained compliance with appl...

Panbela (NASDAQ: PBLA) is a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The company today announced the closing of its public offering of (i) 4,375,000 shares of its common stock or pre-funded warrants in lieu thereof a...

2024-02-01 07:46:07 ET More on Panbela Therapeutics Panbela Therapeutics, Inc. (PBLA) Q3 2023 Earnings Call Transcript Panbela Therapeutics drops on $9M public offering Panbela conducting 1-for-20 reverse stock split Thursday Seeking Alpha’s Quant Rati...

MINNEAPOLIS, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced the closing of its previously announced public offering ...

MINNEAPOLIS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer today announced that an abstract for SBP-101, a proprietary polyamine analogue, has ...

2024-01-29 10:00:02 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...

2024-01-29 07:06:56 ET More on Panbela Therapeutics Panbela Therapeutics, Inc. (PBLA) Q3 2023 Earnings Call Transcript Panbela conducting 1-for-20 reverse stock split Thursday Panbela announces 1-for-20 reverse stock split Seeking Alpha’s Quant Rating ...

MINNEAPOLIS, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced the pricing of a public offering of (i) 4,375,000 shares of its c...

2024-01-26 12:32:20 ET Gainers: Corbus Pharmaceuticals Holdings ( CRBP ) +300% . Aclarion ( ACON ) +66% . Panbela Therapeutics ( PBLA ) +36% . Inspire Veterinary Partners ( IVP ) +36% . Rail Vision Ltd ( RVSN ) +34% . Appfoli...